Medicines

New antibiotic launched

Pfizer has launched Zavicefta (ceftazidime-avibactam) for adults hospitalised with serious infections

Verapamil for rhinosinusitis?

Verapamil dramatically improves symptom scores in patients with chronic rhinosinusitis and nasal polyps

NSAIDs and paracetamol linked to hearing loss

NSAIDs and paracetamol might increase the risk of hearing loss, according to an analysis of 55,850 women

Rotavirus vaccine is preventing gastroenteritis in infants

Infant rotavirus vaccine reduces the number of episodes of acute gastroenteritis by up to half and saves £12.5m a year

Teva launches reformulated levothyroxine range

Teva has launched a reformulated version of levothyroxine, including two previously unavailable strengths

Xultophy approved for renal impairment

Xultophy has been approved for adults with type 2 diabetes and moderate renal impairment

Update: media scare stories cutting statin use?

Media stories questioning the safety of statins are causing people to stop taking the drugs

Update: Enstilar – new psoriasis drug

Enstilar (calcipotriol and betamethasone dipropionate) is a new topical, alcohol-free, foam spray for plaque psoriasis

Massive increase in ADHD prescribing

Prescriptions for ADHD drugs in the UK increased by almost 800 per cent between 2000 and 2015

Benzodiazepines could significantly increase flu risk

Benzodiazepines may increase mortality more than 20-fold in people with influenza-like illness, new research finds

Actavis adds gliclazide 40mg

Actavis has added gliclazide 40mg tablets alongside the existing 80mg tablet offer

New ticagrelor dose

Marketing authorisation has been granted for a 60mg dose of ticagrelor for patients who have suffered a heart attack  

New lung cancer drug

The European Commission has granted marketing authorisation for necitumumab (Portrazza) for lung cancer

Ezetimibe indication widened

The MHRA recently extended the indication for ezetimibe (Ezetrol)

Dementia script numbers rise but costs fall

The number of prescriptions for drugs for Alzheimer’s disease rose more than six-fold over the past decade

GORD quality standards

NICE has published nine quality standards covering GORD in children and young people

Cyramza’s new cancer indications

The European Commission recently approved two new indications for ramucirumab (Cyramza)

Dispensary: Reltebon price cut

Actavis has reduced the list price of Reltebon (oxycodone hydrochloride) prolonged-release tablets

Entresto: a new heart failure drug

Entresto (sacubitril plus valsartan) is now available for adults with symptomatic chronic heart failure.

Dulaglutide gets green light in Scotland

The Scottish Medicines Consortium has accepted Trulicity (dulaglutide) for use in NHS Scotland.  
Previous 1 2 3 Next

Latest

PHE updates guidance on managing common infections

PHE has updated its advice on ’Managing common infections: guidance for primary care’

NHS negligence bill quadruples in a decade

The Government must take steps to rein in the increasing cost of clinical negligence claims as numbers rocket, NAO warns

Views

Flu jabs: let’s do a fantastic job

By NPA chief pharmacist Leyla Hannbeck. If Australia’s experience is anything to go by, we all need to be ready to dea...

Popular

Revealed: how Government spends our money

The Government expects to spend £802 billion in 2017-18, the most it has ever spent in cash terms

Watching Briefs: Clinical skincare

Marketing and brand activity in the clinical skincare category – rounded up

Safety incident reports on the rise, NPA says

The number of medication safety incidents being reported to the NPA is increasing consistently, the Association said